Omeros Corporation
OMER
#6443
Rank
A$1.15 B
Marketcap
A$16.33
Share price
-1.63%
Change (1 day)
-5.08%
Change (1 year)

Omeros Corporation (OMER) - Net assets

Net assets on the balance sheet as of June 2025 : -A$0.35 Billion

According to Omeros Corporation's latest financial reports the company has -A$0.35 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Omeros Corporation - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-A$0.3 Billion700.62%
2023-12-31$-A$36.67 Million-129.12%
2022-12-31$A$0.12 B283.87%
2021-12-31$A$32.8 M-120.89%
2020-12-31$-A$0.16 Billion0.85%
2019-12-31$-A$0.16 Billion9.52%
2018-12-31$-A$0.15 Billion3844.33%
2017-12-31$-A$3.61 Million-93.06%
2016-12-31$-A$51.96 Million44.26%
2015-12-31$-A$36.02 Million-30.91%
2014-12-31$-A$52.12 Million152.88%
2013-12-31$-A$20.62 Million227.95%
2012-12-31$-A$6.29 Million16.02%
2011-12-31$-A$5.42 Million-126.88%
2010-12-31$A$20.15 M-58.04%
2009-12-31$A$48.02 M-137.17%
2008-12-31$-A$0.13 Billion61.53%
2007-12-31$-A$80 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Eterna Therapeutics
ERNA
A$5.37 M-101.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
A$1.84 M-100.54%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
A$140.15 B-40,809.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$119.35 B-34,766.46%๐Ÿ‡บ๐Ÿ‡ธ USA